Arineta announces SpotLight Duo, the world’s first dedicated cardiovascular and thoracic CT system
August 7, 2023 (Caesarea, Israel). Arineta Cardio Imaging is excited to announce the FDA 510(k) clearance of the SpotLight and SpotLight Duo family of cardiovascular CT (CCT) scanners. The two products extend Arineta’s leadership as the only dedicated cardiovascular CT system, and the Duo system adds high-resolution thoracic clinical capability, including for lung cancer, COVID-19, and other pulmonary diseases. Both the SpotLight and SpotLight Duo systems add extended coverage for peripheral vascular and runoff studies, a rapidly growing procedure for vascular therapies.
“Arineta has been the leader in cardiovascular CT technology, and the new SpotLight systems continue Arineta’s history of clinical innovation”, said Scott Schubert, Arineta CEO. “Our vision is to grow cardiac CT as the front-line non-invasive test for diagnosing, therapy planning and monitoring of cardiovascular disease ... the No. 1 cause of death and costs for healthcare worldwide.”
“The recent change in guidelines from the ACC and AHA are now clear that Cardiac CT is the Level 1A evidence recommended test for diagnosis of stable and acute chest pain,” said Chaim Lotan MD, Professor at Hadassah-Hebrew University. “According to the World Health Organization, four of the top six causes of death are cardiovascular and thoracic diseases*.”
The SpotLight system is a 25cm Field of View (FOV) dedicated CCT system, enabled by Arineta’s proprietary Stereo CT technology. SpotLight has best-in-class specifications for temporal resolution (120 msec), 1 beat whole heart coverage (14 cm), spatial resolution (0.5 mm detector), and x-ray tube power for superior image quality (139 kW effective). SpotLight Duo is the 2nd generation of Arineta CT technology, with 45-cm high-resolution scanning for full cardio-thoracic clinical applications. Both systems include workflow advances for higher patient throughput.
At the recent Society of Cardiovascular CT (SCCT) conference, Arineta users presented “Cardiac CT in an office/outpatient setting” and highlighted Arineta’s leadership in bringing CCT to point-of-care. Also showcased was Arineta’s unique Mobile CCT system, which expands access to underserved populations in rural, outpatient and community hospital settings. This will grow Cardiac CT access without requiring a CT scanner and expensive construction at every site.
Arineta SpotLight and SpotLight Duo systems will be sold and serviced directly by Arineta.
SpotLight Duo is the 2nd generation Arineta CT.
Arineta will sell and service directly.
* www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
About us
Arineta Cardio Imaging, an innovative Israeli company, is dedicated to advancing cardiovascular imaging solutions through cutting-edge technology. Since its establishment in late 2006, Arineta has consistently pushed the boundaries of medical imaging.
Located in the prestigious Caesarea Industrial Park, Israel, the company benefits from a rich tradition of medical imaging innovation that traces back to the 1970s. Arineta’s remarkable team comprises a diverse group of highly skilled scientists, engineers, and accomplished business executives, all with an impressive track record in developing and commercializing state-of-the-art medical devices. Their collective expertise and unwavering commitment to excellence have propelled Arineta to the forefront of the industry.
As the world’s first dedicated cardiovascular and thoracic CT system, SpotLight™ Duo incorporates the company’s proprietary Stereo CT technology, revolutionizing cardiac imaging. Arineta continues to drive innovation forward, building upon the legacy of its scientists, who are pioneers of the multi-slice spiral CT technology and have contributed significantly to various key advancements in the field. With an unwavering commitment to delivering state-of-the-art medical devices, Arineta is reshaping the future of cardiovascular and thoracic imaging, ensuring improved patient care and empowering healthcare professionals worldwide.
